SG52707A1 - Proanthocyanidin polymers having antiviral activity and methods of obtaining same - Google Patents

Proanthocyanidin polymers having antiviral activity and methods of obtaining same

Info

Publication number
SG52707A1
SG52707A1 SG1996008125A SG1996008125A SG52707A1 SG 52707 A1 SG52707 A1 SG 52707A1 SG 1996008125 A SG1996008125 A SG 1996008125A SG 1996008125 A SG1996008125 A SG 1996008125A SG 52707 A1 SG52707 A1 SG 52707A1
Authority
SG
Singapore
Prior art keywords
proanthocyanidin polymers
antiviral activity
methods
obtaining same
proanthocyanidin
Prior art date
Application number
SG1996008125A
Other languages
English (en)
Inventor
Michael S Tempesta
Original Assignee
Shaman Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaman Pharmaceuticals Inc filed Critical Shaman Pharmaceuticals Inc
Publication of SG52707A1 publication Critical patent/SG52707A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SG1996008125A 1990-10-12 1991-10-10 Proanthocyanidin polymers having antiviral activity and methods of obtaining same SG52707A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59689390A 1990-10-12 1990-10-12
US07/737,077 US5211944A (en) 1990-10-12 1991-07-29 Proanthocyanidin polymers having antiviral activity and methods of obtaining same

Publications (1)

Publication Number Publication Date
SG52707A1 true SG52707A1 (en) 1998-09-28

Family

ID=27082674

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008125A SG52707A1 (en) 1990-10-12 1991-10-10 Proanthocyanidin polymers having antiviral activity and methods of obtaining same

Country Status (12)

Country Link
US (2) US5211944A (ja)
EP (1) EP0553253B1 (ja)
JP (1) JP3448052B2 (ja)
KR (1) KR100207949B1 (ja)
AT (1) ATE194288T1 (ja)
AU (1) AU660631B2 (ja)
CA (1) CA2093825C (ja)
DE (1) DE69132289D1 (ja)
MX (1) MX9101540A (ja)
NZ (1) NZ240200A (ja)
SG (1) SG52707A1 (ja)
WO (1) WO1992006695A1 (ja)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
US5591770A (en) * 1992-03-31 1997-01-07 The United States Of America As Represented By The Department Of Health And Human Services Calanolide and related antiretroviral compounds, compositions, and uses thereof
JP3103114B2 (ja) * 1992-03-31 2000-10-23 アメリカ合衆国 カラノライド抗ウイルス性化合物、組成物およびその用途
US6774141B1 (en) 1992-03-31 2004-08-10 The United States Of America As Represented By The Secretary Of Health And Human Services Calanolide and related antiviral compounds, compositions, and uses thereof
US5650432A (en) * 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
US5646178A (en) * 1992-10-09 1997-07-08 Jlb, Inc. Cranberry extract and biologically active compounds derived therefrom
ES2247587T3 (es) * 1993-05-28 2006-03-01 New York Blood Center, Inc. Procedimiento para la esterilizacion de composiciones biologicas y el producto producido mediante el mismo.
US5977385A (en) * 1994-08-03 1999-11-02 Sarawak Medichem Pharmaceuticals Method for the preparation of (+)-calanolide A and analogues thereof
US6277879B1 (en) 1994-08-03 2001-08-21 Sarawak Medichem Pharmaceuticals, Inc. Calanolide analogues and methods of their use
US5892060A (en) * 1994-08-03 1999-04-06 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (+)-calanolide a and analogues thereof
US6043271A (en) * 1994-08-03 2000-03-28 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (±)-calanolide A and intermediates thereof
US5554645A (en) * 1994-10-03 1996-09-10 Mars, Incorporated Antineoplastic cocoa extracts and methods for making and using the same
JPH1059846A (ja) * 1996-06-10 1998-03-03 Kikkoman Corp 白内障の予防または治療薬剤
AU775330B2 (en) * 1996-10-16 2004-07-29 Napo Pharmaceuticals Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
CA2269078C (en) 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
US5968973A (en) * 1996-11-18 1999-10-19 Cancer Institute (Hospital), Chinese Academy Of Medical Sciences Method for treating hyperplasia
US6197808B1 (en) * 1996-11-18 2001-03-06 Cancer Instititute (Hospital), Chinese Academy Of Medical Sciences Methods for treating hyperplasia
JP3213557B2 (ja) * 1996-11-18 2001-10-02 三井農林株式会社 茶カテキンを有効成分として含有する尖圭コンジローマ治療剤
AU744527B2 (en) 1997-09-09 2002-02-28 Rutgers, The State University Of New Jersey Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with P-type fimbriae to surfaces
US6060235A (en) 1997-09-19 2000-05-09 Geltex Pharmaceuticals, Inc. Antiviral polymers comprising acid functional groups and hydrophobic groups
WO2000047062A2 (en) * 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
AU4491800A (en) 1999-04-26 2000-11-10 Sarawak Medichem Pharmaceuticals, Inc. Methods for preparing antiviral calanolide compounds
EP1223928A2 (en) 1999-07-08 2002-07-24 Patrick Thomas Prendergast Use of flavones, coumarins and related compounds to treat infections
WO2001011988A2 (en) * 1999-08-13 2001-02-22 Dry Creek Nutrition, Inc. Novel polyphenolic polymeric compositions, method of their isolation, and a method of altering and improving taste characteristics of edible consumables
US6210681B1 (en) 1999-09-07 2001-04-03 Jlb, Inc. Plant proanthocyanidin extracts
WO2001028370A1 (fr) * 1999-10-20 2001-04-26 Daicel Chemical Industries, Ltd. Ingredient pour cigarette et procede de fabrication
US6391330B1 (en) 2000-05-11 2002-05-21 Michael A. Ross Proanthocyanidins and ascorbic acid composition for topical application to human respiratory and oral mucosa
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
US6960360B2 (en) * 2000-08-31 2005-11-01 Phenolics, Llc Efficient method for producing compositions enriched in total phenols
WO2002017945A1 (en) * 2000-08-31 2002-03-07 Hauser, Inc. Efficient method for producing compositions enriched in anthocyanins
EP1213025A1 (de) * 2000-12-06 2002-06-12 Laboratoires Serobiologiques(Societe Anonyme) Kosmetische und/oder dermopharmazeutische Zubereitungen enthaltend Extrakte aus den Blättern der Pflanze Argania spinosa
WO2003080593A1 (fr) * 2002-03-22 2003-10-02 Beijing Jiankai Technology Co., Ltd. Conjugues hydrophiles de polymeres-flavonoides et compositions pharmaceutiques les contenant
AU2003243191B2 (en) 2002-05-02 2007-09-20 President And Fellows Of Harvard College Formulations limiting spread of pulmonary infections
US7208183B2 (en) * 2002-10-05 2007-04-24 Bobrowski Paul J Methods and preparations of the latex from the croton species
US20040071793A1 (en) * 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
ES2536713T3 (es) * 2003-03-12 2015-05-27 Epitome Pharmaceuticals Limited Composiciones para la piel lipófilas de rápida absorción y usos de las mismas
FR2852842A1 (fr) * 2003-03-31 2004-10-01 Silab Sa Procede de preparation d'un principe actif a partir d'exsudat de resine des fruits de daemonorops draco, compositions l'incluant et utilisations
US20050074510A1 (en) * 2003-10-04 2005-04-07 Bobrowski Paul J. Topical preparations for use in treatment of anorectal disease
US20050207983A1 (en) 2004-03-05 2005-09-22 Pulmatrix, Inc. Formulations decreasing particle exhalation
WO2005089780A1 (ja) * 2004-03-18 2005-09-29 Umeda Jimusho Ltd. 抗エイズウイルス性組成物及びウイルス感染細胞の選択的不活化方法
JP2005314316A (ja) * 2004-04-30 2005-11-10 Kikkoman Corp 抗ｓａｒｓコロナウイルス剤
US20070065486A1 (en) * 2004-05-21 2007-03-22 Migco Limited Migraine remedy
ES2245610B1 (es) * 2004-06-23 2007-03-16 Investigacion Y Nutricion, S.L. Producto de origen vegetal y su procedimiento de obtencion.
US20060073220A1 (en) * 2004-07-08 2006-04-06 Daugherty F J Cinnamon extract enriched for polyphenols and methods of preparing same
US20060204600A1 (en) * 2005-03-11 2006-09-14 Paul Konz Dragon's blood anti-viral materials and methods
US20090076132A1 (en) * 2005-03-11 2009-03-19 Gary Pekoe Antiviral compositions and methods of treatment
US20080166426A1 (en) * 2005-03-11 2008-07-10 Gary Pekoe Anitbacterial compositions and methods of treatment
WO2007130892A2 (en) 2006-05-01 2007-11-15 Napo Pharmaceuticals, Inc. Method for treatment of constipation-predominant irritable bowel syndrome
CA2657803C (en) 2006-05-01 2019-01-08 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
JP4892690B2 (ja) * 2008-09-03 2012-03-07 財団法人宮崎県産業支援財団 Ｃ型肝炎ウイルス産生抑制剤
AU2010208429B2 (en) 2009-01-27 2015-08-20 World Force Technologies, Llc A high molecular weight polysaccharide that binds and inhibits virus
EA023814B1 (ru) * 2009-08-26 2016-07-29 Гленмарк Фармасьютикалс Лтд. Способ получения полимерных композиций на основе проантоцианидина для фармацевтических форм
JP5343016B2 (ja) * 2010-01-22 2013-11-13 株式会社ロッテ 抗インフルエンザウイルス剤及びこれを吸着、含浸、添加させてなるインフルエンザ感染抑制用品
EP2448571B1 (en) 2010-08-30 2013-06-12 Pulmatrix, Inc. Respirably dry powder comprising calcium lactate, sodium chloride and leucine
CN105640925B (zh) 2010-08-30 2019-08-16 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
EP2621488B1 (en) 2010-09-29 2018-11-07 Pulmatrix Operating Company, Inc. Cationic dry powders
AU2011308865B2 (en) 2010-09-29 2017-01-05 Pulmatrix, Inc. Monovalent metal cation dry powders for inhalation
WO2012058664A1 (en) 2010-10-31 2012-05-03 Salix Pharmaceuticals, Ltd. Methods and compositions for treating hiv-associated diarrhea
WO2012101008A1 (en) 2011-01-27 2012-08-02 Glenmark Pharmaceuticals Limited Process for the production of proanthocyanidin polymeric composition
NZ629722A (en) 2012-02-29 2017-03-31 Pulmatrix Operating Co Inc Inhalable dry powders
IN2014MN01933A (ja) * 2012-03-13 2015-07-10 Piramal Entpr Ltd
KR101349609B1 (ko) * 2012-06-08 2014-01-09 순천향대학교 산학협력단 어류의 백신분석을 위한 indicator 및 이를 이용한 어류용 백신 분석방법
CN105324106A (zh) 2013-04-01 2016-02-10 普马特里克斯营业公司 噻托铵干粉
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
KR20210145207A (ko) * 2019-03-29 2021-12-01 에보니크 오퍼레이션즈 게엠베하 헤르페스비리다에에 의해 유발된 바이러스 감염의 예방 및/또는 치료에 사용하기 위한 베리 추출물을 함유하는 제제
CN114624367B (zh) * 2020-12-14 2023-05-09 四川大学 一种采用固态氧鎓盐无溶剂加压提取竹叶黄酮的方法
US20230060934A1 (en) * 2021-08-25 2023-03-02 Michael Wayne Dockery Botanical antiviral nutritional supplement

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2226185A1 (en) * 1973-04-20 1974-11-15 Vincent Yves Therapeutically active tannin fractions prepd. - from Cupressus sempervirens fruits by extracting with solvents
CA1086651A (en) * 1977-12-12 1980-09-30 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Health And Welfare Canada Compositions for, and treatment of, herpes viral infections
US4335110A (en) * 1979-08-23 1982-06-15 Orewa Inc. Pharmaceutical compositions of sanguinaria galangal and zinc chloride
JPS59196884A (ja) * 1983-04-20 1984-11-08 Nippon Shinyaku Co Ltd 新規なるタンニン
JPS61205272A (ja) * 1985-03-08 1986-09-11 Tsumura Juntendo Inc 新規なタンニン
US4698360B1 (en) * 1985-04-09 1997-11-04 D Investigations Pharmacologiq Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof
GB8518289D0 (en) * 1985-07-19 1985-08-29 Inverni Della Beffa Spa Obtaining proanthocyanidine a2
JPH0231074B2 (ja) * 1986-08-26 1990-07-11 Nippon Shinyaku Co Ltd Shintannin
CA2001898A1 (en) * 1988-10-31 1990-04-30 Kuo-Hsiung Lee Inhibition of human retroviruses
ES2078339T3 (es) * 1989-05-12 1995-12-16 Cariel Leon Composiciones a base de proantocianidoles; su aplicacion farmacologica.

Also Published As

Publication number Publication date
JPH06502413A (ja) 1994-03-17
CA2093825C (en) 2003-01-07
KR930702010A (ko) 1993-09-08
AU8878091A (en) 1992-05-20
MX9101540A (es) 1992-06-05
CA2093825A1 (en) 1992-04-13
WO1992006695A1 (en) 1992-04-30
ATE194288T1 (de) 2000-07-15
DE69132289D1 (de) 2000-08-10
NZ240200A (en) 1994-04-27
JP3448052B2 (ja) 2003-09-16
US5211944A (en) 1993-05-18
EP0553253A4 (en) 1993-09-15
KR100207949B1 (ko) 1999-07-15
EP0553253A1 (en) 1993-08-04
AU660631B2 (en) 1995-07-06
US5494661A (en) 1996-02-27
EP0553253B1 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
EP0553253A4 (en) Proanthocyanidin polymers having antiviral activity and methods of obtaining same
MY104343A (en) Novel pyridizinamine deravatives
DE69018654D1 (de) Abgeschirmte Heissspritzpistole und Verwendung derselben.
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
ES2014266B3 (es) Producto protector de la madera.
EP0414304A3 (en) Use of viruses against undesirable micro-organisms
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
EP0608212A4 (en) PROCESS FOR TREATING VIRAL INFECTIONS.
GR3032237T3 (en) Method for inhibition of viral morphogenesis.
FI961380A0 (fi) Koostumuksia virusten aiheuttamien kasvainten ehkäisemiseksi ja hoitamiseksi
IT1244560B (it) Procedimento impianto per il trattamento di depurazione, di fumi, polveri o gas di scarico dopo la combustione.
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
AU587716B2 (en) Method for cooling gases and/or vapours from non ferrous metal treatment plants, and the relative apparatus
NZ213370A (en) Method of treating viral infections of selected trees and field crops using ribavirin (1-b-d-ribofuranosyl-1,2,4-triazole-3-carboxamide) or the 2,3,5-triacetyl or 5'-butyryl derivative thereof
EP0259617A3 (en) Process and preparation for inactivating viruses
GB2224209B (en) Method for preventing or inhibiting plant virus diseases
IT1112692B (it) Purificatore dell'aria,specie cappa aspirante per cucine o similare
AU7145891A (en) Nailing system for treating fractures, particularly cervico-trochanterian and pertrochanterian fractures
ATE44801T1 (de) Vorrichtung zur behandlung von rauchgas, insbesondere auspuffgas.
EP0369749A3 (en) Anti-tumor compounds
DE69022154D1 (de) "RTM"-Verarbeitungsanlage und Verfahren.
BG101909A (en) Pesticides
GR960100092A (el) Νεα (2η) φαρμακευτικη χρηση του σκορδου για την παρασκευη οποιασδηποτε μορφης φαρμακου για την θεραπειαν του επιχειλιου ερπητος και του ερπητος των γεννητικων οργανων.
UA23352A (uk) beta- D- ГЛЮКОЗАМОHІЙHА СІЛЬ alРha-БРОМІЗОВАЛЕРІАHОВОЇ КИСЛОТИ, ЯКА МАЄ ПРОТИВІРУСHУ АКТИВHІСТЬ ВІДHОСHО ВІРУСУ ВЕЗИКУЛЯРHОГО СТОМАТИТУ, ВІРУСУ ПРОСТОГО ГЕРПЕСУ ТА КОРОHАВІРУСУ
UA22189A (uk) Іі-кабетоксифеhілакоhітімід, який виявляє активhість відhосhо вірусу везикулярhого стоматиту та вірусу простого герпесу